These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31812470)

  • 1. Reply-Letter to the Editor: Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease.
    Kim M; Jun DW
    Clin Nutr; 2020 Jan; 39(1):306. PubMed ID: 31812470
    [No Abstract]   [Full Text] [Related]  

  • 2. Errors in meta-analysis should be corrected in "Critical appraisal for low-carbohydrate diet in non-alcoholic fatty liver disease: Review and meta-analyses".
    Henschel B; Dickinson SL; Allison DB
    Clin Nutr; 2021 Jul; 40(7):4535-4536. PubMed ID: 34229256
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter-to-the-editor on "A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice".
    Wang X; Jiang B
    Mol Metab; 2024 Mar; 81():101898. PubMed ID: 38360108
    [No Abstract]   [Full Text] [Related]  

  • 4. Response-to Letter-to-the-editor: "A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice".
    Wolfrum C; Challa TD
    Mol Metab; 2024 Mar; 81():101897. PubMed ID: 38354855
    [No Abstract]   [Full Text] [Related]  

  • 5. Summary for Patients: Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Ann Intern Med; 2023 Jan; 176(1):I18. PubMed ID: 36508738
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
    Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
    Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to the Letter to the Editor Entitled: "The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases".
    Turan Y
    Angiology; 2020 Jan; 71(1):88. PubMed ID: 31597437
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease".
    Kutlu O; Altun Ö; Dikker O; Aktaş Ş; Özsoy N; Arman Y; Özgün Çil E; Özcan M; Aydın Yoldemir Ş; Akarsu M; Toprak İD; Kırna K; Kutlu Y; Toprak Z; Eruzun H; Tükek T
    Med Princ Pract; 2020; 29(1):98. PubMed ID: 31505512
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial.
    Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Haghighatdoost F; Azadbakht L
    Horm Metab Res; 2017 Sep; 49(9):687-692. PubMed ID: 28759939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to the Letter to the Editor by Li et al.: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E.
    Kobori M; Takahashi Y; Sakurai M; Ni Y; Chen G; Nagashimada M; Kaneko S; Ota T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.
    Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A
    Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply-Letter to the editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Jun DW; Lee S
    Clin Nutr; 2018 Jun; 37(3):1090. PubMed ID: 29478888
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply Letter to the Editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Lee SM; Jun DW
    Clin Nutr; 2018 Apr; 37(2):759. PubMed ID: 29366517
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to the Letter to the Editor Entitled "NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?".
    Turan Y; Demir V; Turan E; Hidayet Ş
    Angiology; 2020 Jan; 71(1):85-86. PubMed ID: 31450946
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use.
    Carrieri P; Duracinsky M; Marcellin F; Lazarus JV
    Hepatology; 2019 Jul; 70(1):443-444. PubMed ID: 30472796
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-carbohydrate diets and intrahepatic lipid content in individuals with non-alcoholic fatty liver disease: Evidence from a meta-analysis of randomized trials.
    Bueno NB; Dos Santos Silva MM; de Melo ISV
    Clin Nutr; 2020 Jan; 39(1):310-311. PubMed ID: 31791671
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply-letter to the editor: Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg?
    Lan Y; Wang L
    Clin Nutr; 2021 Nov; 40(11):5445-5446. PubMed ID: 34653824
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease.
    McHenry S; Ciorba MA; Deepak P
    Inflamm Bowel Dis; 2020 May; 26(6):e46. PubMed ID: 32130410
    [No Abstract]   [Full Text] [Related]  

  • 19. In Reply-Diet and Activity Programs Are Ineffective in Nonalcoholic Fatty Liver Disease.
    Spengler EK; Loomba R
    Mayo Clin Proc; 2016 May; 91(5):684-5. PubMed ID: 27150216
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply-Letter to the Editor-Is liver steatosis diagnostic of non-alcoholic fatty liver disease in patients with hereditary fructose intolerance?
    Aldamiz-Echevarria L; Villate O
    Clin Nutr; 2019 Aug; 38(4):1962. PubMed ID: 31104878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.